Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...
This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...
Similarly, the now enabled timsOmni deep proteoform methods are equally powerful in interrogating drug targets, as well as biologics, including therapeutic antibodies, ADCs, multispecifics, and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results